# Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis

> **NCT06463678** · PHASE2 · NOT_YET_RECRUITING · sponsor: **IVIEW Therapeutics Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Fungal Keratitis

## Interventions

- **DRUG:** IVIEW-1201
- **DRUG:** NATACYN®

## Key facts

- **NCT ID:** NCT06463678
- **Lead sponsor:** IVIEW Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06463678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06463678, "Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT06463678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*